Catheter that delivers oxygen directly into the blood
Raised to date
$1.6M
of $1.6M offered across 1 Form D filing
VQ Biomedical, Inc. is a pioneering medical device company specializing in advanced healthcare solutions for patients suffering from acute respiratory distress syndrome (ARDS) and other severe lung injuries. By developing innovative technologies, the company aims to improve patient outcomes and enhance the quality of care provided in critical health situations.
VQ Biomedical differentiates itself through the development of a minimally invasive catheter that delivers supplemental oxygen directly into the bloodstream, effectively facilitating patient recovery while ensuring minimal disruption to their existing health conditions.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 27, 2025 | Debt | $1.6M/ $1.6M | Form D |
Medical Device
This innovative catheter is designed to administer supplemental oxygen directly into the bloodstream of patients with severe lung injury. It offers a novel approach to treating conditions where mechanical ventilation and ECMO are traditionally used.
Built for
Hospitals and healthcare providers
